DNM2 levels normalization improves muscle phenotypes of a novel mouse model for moderate centronuclear myopathy

Juliana de Carvalho Neves(Centre National de la Recherche Scientifique), Jocelyn Laporte(Centre National de la Recherche Scientifique)

Molecular Therapy — Nucleic Acids

July 17, 2023

10.1016/j.omtn.2023.07.003

Cited by 11

Related Papers

Inactivating the lipid kinase activity of PI3KC2β is sufficient to rescue myotubular myopathy in mice

|JCI Insight|2023|15

MTM1 overexpression prevents and reverts BIN1-related centronuclear myopathy

|Brain|2023|13